3-(2-(3,4-dimethoxyphenyl)ethyl)-2,3-dihydro-2-thioxoquinazolin-4(1H)-one | 361150-63-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 英文名称: 3-(2-(3,4-dimethoxyphenyl)ethyl)-2,3-dihydro-2-thioxoquinazolin-4(1H)-one
• 英文别名: 3-(3,4-dimethoxyphenethyl)-2,3-dihydro-2-thioxoquinazolin-4(1H)-one；3-[2-(3,4-Dimethoxy-phenyl)-ethyl]-2-mercapto-3H-quinazolin-4-one；3-[2-(3,4-dimethoxyphenyl)ethyl]-2-sulfanylidene-1H-quinazolin-4-one
• CAS: 361150-63-2
• 化学式: C₁₈H₁₈N₂O₃S
• mdl: MFCD00126085
• 分子量: 342.419
• InChiKey: AHPDQPJQSCAGGL-UHFFFAOYSA-N

物化性质

• 沸点：
  508.4±60.0 °C(Predicted)
• 密度：
  1.33±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  82.9
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-(2-(3,4-dimethoxyphenyl)ethyl)-2,3-dihydro-2-thioxoquinazolin-4(1H)-one 在 copper(ll) sulfate pentahydrate 、 potassium carbonate 、 sodium ascorbate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 32.0h， 生成 3-(3,4-dimethoxyphenethyl)-2-(((1-(4-methylbenzyl)-1H-1,2,3-triazol-4-yl)methyl)thio) quinazolin-4(3H)-one
  参考文献：
  名称：

  Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study

  摘要：

  A novel series of quinazolinone-1,2,3-triazole hybrids 10a-p were designed, synthesized, and evaluated for their in vitro alpha-glucosidase inhibitory activity leading to efficient anti-diabetic agents. All synthesized compounds exhibited good inhibitory activity against yeast alpha-glucosidase (IC50 values in the range of 181.0-474.5 mu M) even much more potent than standard drug acarbose (IC50 = 750.0). Among them, quinazolinone-1,2,3-triazoles possessing 4-bromobenzyl moiety connected to 1,2,3-triazole ring (10g and 10p) demonstrated the most potent inhibitory activity towards alpha-glucosidase. Compound 10g inhibited alpha-glucosidase in a competitive manner with K-i value of 117 mu M. Furthermore, the binding modes of the most potent compounds 10g and 10p in the alpha-aglucosidase active site was studied through in silico docking studies. Also, lack of cytotoxicity of compounds 10g and 10p was confirmed via MTT assay.

  DOI：

  10.1016/j.bioorg.2018.10.023
• 作为产物：
  描述：

  3,4-二甲氧基苯乙胺 在 potassium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 20.0h， 生成 3-(2-(3,4-dimethoxyphenyl)ethyl)-2,3-dihydro-2-thioxoquinazolin-4(1H)-one
  参考文献：
  名称：

  新型喹唑啉-磺胺衍生物：合成、表征、生物学评价和分子对接研究

  摘要：

  摘要 在新药的设计中，通过几种药效团的组合形成杂合分子可以产生具有有趣生化特征的化合物。合成、表征和评估了一系列新型喹唑啉-磺胺衍生物 ( 9a-m )的体外抗糖尿病、抗胆碱能和抗癫痫活性。这些合成的新型喹唑啉-磺胺衍生物（9a-m) 被发现是 α-糖苷酶、人碳酸酐酶 I 和 II (hCA I 和 hCA II)、丁酰胆碱酯酶 (BChE) 和乙酰胆碱酯酶 (AChE) 酶的有效抑制剂分子，Ki 值范围为 100.62 ± 13.68– α-糖苷酶为 327.94 ± 58.21 nM，hCA I 为 1.03 ± 0.11–14.87 ± 2.63 nM，hCA II 为 1.83 ± 0.24–15.86 ± 2.57 nM，BChE 为 30.12 ± 3.81–102.16 ± 13.87 nM，和 26..15–8 ± 3对于 AChE，分别为 ± 20.11 nM。在最后一步

  DOI：

  10.1080/07391102.2020.1847193

文献信息

• Convenient and sequential one-pot route for synthesis of 2-thioxoquinazolinone and quinazolinobenzothiazinedione derivatives
  作者：Mehdi Asadi、Shiva Masoomi、Seyed Mostafa Ebrahimi、Mohammad Mahdavi、Mina Saeedi、Abbas Shafiee、Alireza Foroumadi

  DOI：10.1007/s00706-013-1110-8

  日期：2014.3

  AbstractA new and efficient synthetic process has been developed for preparation of 2-thioxoquinazolinone and quinazolinobenzothiazinedione derivatives. The related products were synthesized through reaction of isatoic anhydride, amines/anthranilic acids, and carbon disulfide (CS2) in the presence of potassium hydroxide in ethanol at reflux. Graphical abstract

  摘要已经开发出一种新的有效的合成方法来制备2-硫代氧杂喹唑啉酮和喹唑啉基苯并噻嗪二酮衍生物。在乙醇中，在氢氧化钾存在下，通过等角酸酐，胺/邻氨基苯甲酸和二硫化碳（CS 2）反应合成相关产物。 图形概要
• Design, synthesis, in vitro and in silico biological assays of new quinazolinone-2-thio-metronidazole derivatives
  作者：Samira Ansari、Maryam Mohammadi-Khanaposhtani、Mohammad Sadegh Asgari、Ensieh Nasli Esfahani、Mahmood Biglar、Bagher Larijani、Hossein Rastegar、Haleh Hamedifar、Mohammad Mahdavi、Recep Tas、Parham Taslimi

  DOI：10.1016/j.molstruc.2021.130889

  日期：2021.11

  A new series of quinazolinone-2-thio-metronidazole derivatives 9a-o was designed, synthesized and assayed for their activities against metabolic enzymes human carbonic anhydrase I and II (hCAs I and II), acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and α-glucosidase. The results indicated that all the synthesized compounds exhibited excellent inhibitory activities against mentioned enzymes

  设计、合成了一系列新的喹唑啉酮-2-硫代甲硝唑衍生物9a-o，并测定了它们对代谢酶人类碳酸酐酶 I 和 II（hCAs I 和 II）、乙酰胆碱酯酶（AChE）、丁酰胆碱酯酶（BChE）、和α-葡萄糖苷酶。结果表明，与标准抑制剂相比，所有合成的化合物对上述酶均表现出优异的抑制活性。具有代表性的是，对 CA 酶最有效的化合物 4-氟苯基衍生物9i 分别是标准抑制剂乙酰唑胺对 hCA I 和 II 的 4 倍和 7 倍；4-氟苄基衍生物9m作为对抗胆碱酯酶的最有效化合物，其对抗 AChE 和 BChE 的效力分别是标准抑制剂他克林的 11 倍和 21 倍；具有 4-甲氧基苯基部分的最活跃的 α-葡萄糖苷酶抑制剂9h 的活性是作为标准抑制剂的阿卡波糖的 5 倍。此外，为了研究相关酶活性位点中最有效化合物的相互作用模式，进行了分子建模。还预测了化合物9i、9m和9h 的药物相似性、ADME 和毒性特征。
• A green and efficient synthesis of 2-thioxoquinazolinone derivatives in water using potassium thiocyanate
  作者：Ghasem Rezanejade Bardajee、Aseyeh Ghaedi、Shohreh Hekmat、Ghazale Abarashi、Mohammad Mahdavi、Tahmineh Akbarzadeh

  DOI：10.1080/17415993.2017.1325891

  日期：2017.9.3

  ABSTRACT Green chemistry is one of the most important routes for the synthesis of heterocyclic compounds. In this regard, the synthesis of 2-thioxoquinazolinone derivatives was achieved by condensation of versatile materials including isatoic anhydride, amine and potassium thiocyanate in the green medium of water. This convenient and efficient method affords the desired products with good to excellent yields

  摘要 绿色化学是合成杂环化合物最重要的途径之一。在这方面，2-硫代喹唑啉酮衍生物的合成是通过多种材料在水的绿色介质中缩合而成的，包括靛红酸酐、胺和硫氰酸钾。这种方便而有效的方法可以提供具有良好到极好的收率的所需产品。图形概要
• Novel quinazolin–sulfonamid derivatives: synthesis, characterization, biological evaluation, and molecular docking studies
  作者：Nima Sepehri、Maryam Mohammadi-Khanaposhtani、Nafise Asemanipoor、Samanesadat Hosseini、Mahmood Biglar、Bagher Larijani、Mohammad Mahdavi、Haleh Hamedifar、Parham Taslimi、Nastaran Sadeghian、Mostafa Norizadehtazehkand、Ilhami Gulcin

  DOI：10.1080/07391102.2020.1847193

  日期：2022.5.24

  In the design of novel drugs, the formation of hybrid molecules via the combination of several pharmacophores can give rise to compounds with interesting biochemical profiles. A series of novel quinazolin–sulfonamid derivatives (9a–m) were synthesized, characterized and evaluated for their in vitro antidiabetic, anticholinergics, and antiepileptic activity. These synthesized novel quinazolin–sulfonamid

  摘要 在新药的设计中，通过几种药效团的组合形成杂合分子可以产生具有有趣生化特征的化合物。合成、表征和评估了一系列新型喹唑啉-磺胺衍生物 ( 9a-m )的体外抗糖尿病、抗胆碱能和抗癫痫活性。这些合成的新型喹唑啉-磺胺衍生物（9a-m) 被发现是 α-糖苷酶、人碳酸酐酶 I 和 II (hCA I 和 hCA II)、丁酰胆碱酯酶 (BChE) 和乙酰胆碱酯酶 (AChE) 酶的有效抑制剂分子，Ki 值范围为 100.62 ± 13.68– α-糖苷酶为 327.94 ± 58.21 nM，hCA I 为 1.03 ± 0.11–14.87 ± 2.63 nM，hCA II 为 1.83 ± 0.24–15.86 ± 2.57 nM，BChE 为 30.12 ± 3.81–102.16 ± 13.87 nM，和 26..15–8 ± 3对于 AChE，分别为 ± 20.11 nM。在最后一步
• Design and synthesis of novel quinazolinone-1,2,3-triazole hybrids as new anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and docking study
  作者：Mina Saeedi、Maryam Mohammadi-Khanaposhtani、Parvaneh Pourrabia、Nima Razzaghi、Reza Ghadimi、Somaye Imanparast、Mohammad Ali Faramarzi、Fatemeh Bandarian、Ensieh Nasli Esfahani、Maliheh Safavi、Hossein Rastegar、Bagher Larijani、Mohammad Mahdavi、Tahmineh Akbarzadeh

  DOI：10.1016/j.bioorg.2018.10.023

  日期：2019.3

  A novel series of quinazolinone-1,2,3-triazole hybrids 10a-p were designed, synthesized, and evaluated for their in vitro alpha-glucosidase inhibitory activity leading to efficient anti-diabetic agents. All synthesized compounds exhibited good inhibitory activity against yeast alpha-glucosidase (IC50 values in the range of 181.0-474.5 mu M) even much more potent than standard drug acarbose (IC50 = 750.0). Among them, quinazolinone-1,2,3-triazoles possessing 4-bromobenzyl moiety connected to 1,2,3-triazole ring (10g and 10p) demonstrated the most potent inhibitory activity towards alpha-glucosidase. Compound 10g inhibited alpha-glucosidase in a competitive manner with K-i value of 117 mu M. Furthermore, the binding modes of the most potent compounds 10g and 10p in the alpha-aglucosidase active site was studied through in silico docking studies. Also, lack of cytotoxicity of compounds 10g and 10p was confirmed via MTT assay.